Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Lee Sung. Director active across 4 companies, notably Vir Biotechnology, Inc.. Aggregated, 27 reports have been published. Split: 0 buy · 4 sells. Total volume traded: €322k. History available since 27 March 2023. The latest transaction was disclosed on 29 April 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Lee Sung
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6,008 shares@ US$9.8875100.0% of flowCommon StockSEC:0001628280-24-013555:0
25 of 27 declarations
About Lee Sung
Lee Sung has filed 27 disclosures in total. Across the 27 recent sampled filings between 2023-03-29 and 2026-06-29, the activity is dominated by option exercises, with 0 EUR of buys and 321555 EUR of sells, mainly at Cytokinetics INC and also at Vir Biotechnology, Inc. and Tango Therapeutics, Inc.